RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,620 | -16.3% | 1,500 | 0.0% | 0.00% | – |
| Q2 2023 | $1,935 | -2.3% | 1,500 | 0.0% | 0.00% | – |
| Q1 2023 | $1,980 | -12.0% | 1,500 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $2,250 | +12.5% | 1,500 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -50.0% | 1,500 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $4,000 | 0.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $4,000 | -20.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $5,000 | -28.6% | 1,500 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $7,000 | +40.0% | 1,500 | 0.0% | 0.00% | +100.0% |
| Q1 2021 | $5,000 | 0.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | +25.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $4,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |